Epidemiology of S. aureus Non-Susceptible to Vancomycin in Western Asia

Zean Zefenkey; Salah Mahdi  Al-Bader; Hama Tellawi

doi:10.21271/ZJPAS.36.6.4

Authors

Zean Zefenkey Department of Medical Laboratory Science, College of Science, Knowledge University, Erbil 44001, Iraq
Salah Mahdi Al-Bader Department of Community Health Nursing, College of Science, Cihan University-Erbil, Kurdistan Region, Iraq
Hama Tellawi Department of Microbiology, College of Pharmacy, A-Wataniya Private University, Hama, Syria.

DOI:

https://doi.org/10.21271/ZJPAS.36.6.4

Keywords:

Vancomycin-resistant S. aureus, methicillin-resistant S. aureus, Vancomycin non-susceptible S. aureus, Asia.

Abstract

Staphylococcus aureus is considered among the most severe hazardous bacteria, especially, after the emergence of methicillin-resistant Staphylococcus aureus, that associated with significant levels of pathogenicity along with mortality. Vancomycin is the treatment of choice for methicillin-resistant Staphylococcus aureus infections worldwide. Unfortunately, Vancomycin non-susceptible Staphylococcus aureus strains have also emerged, making controlling Staphylococcus aureus infections an international health challenge. The availability of accurate epidemiological information from all over the world aids in developing the best surveillance and control programs, limiting the spread and evolution of infections. In this paper, we review the mechanism of vancomycin non-susceptibility among Staphylococcus aureus and focus on the emergence, epidemiological characteristics, and the latest progress in Western Asia.

References

Ahmed, O. B., Bahwerth, F. S., Alsafi, R., Elsebaei, E. A., Ebid, G. T., Theyab, A., & Assaggaf, H. (2024). The Prevalence and Antimicrobial Susceptibility of Methicillin-Resistant Staphylococcus aureus Before and After the COVID-19 Pandemic in a Tertiary Saudi Hospital. Cureus, 16(2), e54809.

Al Rahmany, D., Albeloushi, A., Alreesi, I., Alzaabi, A., Alreesi, M., Pontiggia, L., and Ghazi, I. M. 2019. Exploring bacterial resistance in Northern Oman, a foundation for implementing evidence-based antimicrobial stewardship program. International Journal of Infectious Diseases, 83, 77-82.

Aligholi, M., Emaneini, M., Jabalameli, F., Shahsavan, S., Dabiri, H., and Sedaght, H. 2008. Emergence of high-level vancomycin-resistant Staphylococcus aureus in the Imam Khomeini Hospital in Tehran. Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 17(5), 432–434.

Almuhayawi, M. S., Alruhaili, M. H., Gattan, H. S., Alharbi, M. T., Nagshabandi, M., Al Jaouni, S., ... and Elnosary, M. E. (2023). Staphylococcus aureus induced wound infections which antimicrobial resistance, methicillin-and vancomycin-resistant: assessment of emergence and cross sectional study. Infection and Drug Resistance, 5335-5346.

Almutairi, H., Albahadel, H., Alhifany, A. A., Aldalbahi, H., Alnezary, F. S., Alqusi, I., ... and Almutairi, M. S. (2024). Prevalence and antimicrobial susceptibility pattern of methicillin-resistant Staphylococcus aureus (MRSA) at a maternity and children hospital in Saudi Arabia: A cross-sectional study. Saudi Pharmaceutical Journal, 32(4), 102001.

Al-Mustafa, Z. H., and M. S. Al-Ghamdi. 2002. Use of antibiotics in the poultry industry in Saudi Arabia: implications for public health. Annals of Saudi Medicine, 22, 4–7.

Al-Obeid, S., Haddad, Q., Cherkaoui, A., Schrenzel, J., and Francois, P. 2010. First detection of an invasive Staphylococcus aureus strain (D958) with reduced susceptibility to glycopeptides in Saudi Arabia. Journal of clinical microbiology, 48(6), 2199-2204.

AlSaleh, A., Shahid, M., Farid, E., Saeed, N., Bindayna, K. M., and Farid IV, E. 2023. Multidrug-Resistant Staphylococcus aureus Isolates in a Tertiary Care Hospital, Kingdom of Bahrain. Cureus, 15(4).

Al-Said, H. M., Alghamdi, A., Ashgar, S. S., Jalal, N. A., Faidah, H. S., Johargy, A. K., ... and Khidir, E. B. (2023). Isolation and detection of drug-resistant bacterial pathogens in postoperative wound infections at a tertiary care hospital in Saudi Arabia. Saudi Journal of Medicine & Medical Sciences, 11(3), 229-234.

Alzolibani, A. A., Al Robaee, A. A., Al Shobaili, H. A., Bilal, J. A., Ahmad, M. I., and Saif, G. B. 2012. Documentation of vancomycin-resistant Staphylococcus aureus (VRSA) among children with atopic dermatitis in the Qassim region, Saudi Arabia. Acta Dermatovenerol Alp Pannonica Adriat, 21(3), 51-53.

Appelbaum PC. 2007. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA). International Journal of Antimicrobial Agents 30, 398–408.

Arthur M, Courvalin P. 1993. Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob Agents Chemother, 37(8):1563–71.

Asadpour, L., Ghazanfari, N. 2019. Detection of vancomycin nonsusceptible strains in clinical isolates of Staphylococcus aureus in northern Iran. International Microbiol 22, 411–417.

Aslanimehr, M., Attar, A., and Barikani, A. (2024). Phenotypic and Molecular Characterization of Vancomycin and Linezolid Resistance in Clinical Isolates of Staphylococcus aureus. Archives of Clinical Infectious Diseases, 19(3).

Azimian, A., Havaei, S. A., Fazeli, H., Naderi, M., Ghazvini, K., Samiee, S. M., ... & Peerayeh, S. N. 2012. Genetic characterization of a vancomycin-resistant Staphylococcus aureus isolate from the respiratory tract of a patient in a university hospital in northeastern Iran. Journal of clinical microbiology, 50(11), 3581-3585.

Baede, V.O.; David, M.Z.; Andrasevic, A.T.; Blanc, D.S.; Borg, M.; Brennan, G.; Catry, B.; Chabaud, A.; Empel, J.; Enger, H.; et al. 2022. MRSA surveillance programmes worldwide: Moving towards a harmonised international approach. Int. J. Antimicrob. Agents, 59, 106538.

Barna JC, Williams DH. 1984. The structure and mode of action of glycopeptide antibiotics of the vancomycin group. Annual Review of Microbiology, 38, 339–357

Bondi A Jr, Dietz CC. 1945. Penicillin resistant staphylococci. Proc Soc Exp Biol Med, 60:55–58.

Centers for Disease Control and Prevention. 2024. Infection Control Guidance: Preventing Methicillin-resistant Staphylococcus aureus (MRSA) in Healthcare Facilities. Last accessed date on 11 October 2024. Available from : https://www.cdc.gov/mrsa/hcp/infection-control/index.html

Chen, H., Liu, Y., Sun, W., Chen, M. and Wang, H. 2011. The incidence of heterogeneous vancomycin-intermediate Staphylococcus aureus correlated with increase of vancomycin MIC. Diagnostic Microbiology and Infectious Disease, 71, 301–303.

Cheung, G. Y. C., Bae, J. S., and Otto, M. 2021. Pathogenicity and virulence of Staphylococcus aureus. Virulence, 12(1), 547–569.

Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty– Seventh Informational Supplement. CLSI Document M100-S27. Wayne: CLSI; 2017.

Cong, Y., Yang, S., Rao, X. 2020. Vancomycin resistant Staphylococcus aureus infections: A review of case updating and clinical features. Journal of Advanced Research, 21, 169–176

Coombs, G. W., Daley, D. A., Yee, N. W., Shoby, P., and Mowlaboccus, S. 2022. Australian group on antimicrobial resistance (AGAR) Australian Staphylococcus aureus sepsis outcome programme (ASSOP) annual report 2020. Communicable Diseases Intelligence, 46, 1–17.

Dezfulian, A., Aslani, M. M., Oskoui, M., Farrokh, P., Azimirad, M., Dabiri, H., ... & Zali, M. R. 2012. Identification and characterization of a high vancomycin-resistant Staphylococcus aureus harboring VanA gene cluster isolated from diabetic foot ulcer. Iranian journal of basic medical sciences. 15(2), 803.

e Oliveira, D.M.P.; Forde, B.M.; Kidd, T.J.; Harris, P.N.A.; Schembri, M.A.; Beatson, S.A.; Paterson, D.L.; Walker, M.J. 2020. Antimicrobial resistance in ESKAPE pathogens. Clinical Microbiology Reviews, 33, e00181-19.

El Ayoubi, M. D., Hamze, M., Mallat, H., Achkar, M., & Dabboussi, F. 2014. Glycopeptide intermediate Staphylococcus aureus and prevalence of the luk-PV gene in clinical isolates, in Northern Lebanon. Medecine et maladies infectieuses, 44(5), 223-228.

Enger, H., Larssen, K. W., Damås, E. S., Aamot, H. V., Blomfeldt, A., Elstrøm, P., et al. 2022. A tale of two STs: Molecular and clinical epidemiology of MRSA t304 in Norway 2008–2016. European Journal of Clinical Microbiology & Infectious Diseases, 41, 209–218.

Gazel, D., Erinmez, M., Manay, A. B., & Zer, Y. 2021. Investigation of heteroresistant vancomycin intermediate Staphylococcus aureus among MRSA isolates. The Journal of Infection in Developing Countries, 15(01), 89-94.

Haaber J, Friberg C, McCreary M, Lin R, Cohen SN, Ingmer H. 2015. Reversible antibiotic tolerance induced in Staphylococcus aureus by concurrent drug exposure. MBio, 6, e02268-14.

Gümüş, H. H. (2023). Prevalence and resistance trends of Gram positive cocci Staphylococcus aereus and Enterococcus spp. in a tertiary care hospital. Cukurova Medical Journal, 48(3), 1177-1186.

Hamza, H. J., Jebur, M. H., Ramadan, G. M., and Ali, J. A. (2024). Molecular Detection of Vancomycin Resistance Genes in Staph aureus Isolates from Different Clinical Specimens. Current Research in Nutrition and Food Science Journal, 12(1), 320-329.

Hantoosh, S. M. 2022. Nasal Carriage of Vancomycin-and Methicillin-Resistant Staphylococcus aureus among Intermediate Students of Urban and Rural Schools of Muthanna Province in Iraq. Iraqi Journal of Pharmaceutical Sciences, 31(1), 102-108.

Havaei, S. A., Azimian, A., Fazeli, H., Naderi, M., Ghazvini, K., Samiee, S. M., ... and Akbari, M. 2012. Genetic characterization of methicillin resistant and sensitive, vancomycin intermediate Staphylococcus aureus strains isolated from different Iranian Hospitals. International Scholarly Research Notices, 2012.

Hemmadi, V.; Biswas, M. 2020. An overview of moonlighting proteins in Staphylococcus aureus infection. Archives of Microbiology, 203, 481–498

Holmes, N.E.; Turnidge, J.D.; Munckhof, W.J.; Robinson, J.O.; Korman, T.; O’Sullivan, M.; Anderson, T.L.; Roberts, S.A.; Gao, W.; Christiansen, K.J.; et al. 2011. Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations. Journal of Infectious Diseases, 204, 340–347.

Hussein Azzam, B. 2006. Resistance of staphylococcus aureus to vancomycin in Zarqa, Jordan, 144-148.

Jain, A., Kumar Oli, A., Kulkarni, S., D Kulkarni, R., and Chandrakanth, K. (2024). A review on drug resistance patho-mechanisms in ESKAPE bacterial pathogens. Novel Research in Microbiology Journal, 8(3), 2435-2451.

Jansen, A.; Türck, M.; Szekat, C.; Nagel, M.; Clever, I.; Bierbaum, G. 2007. Role of insertion elements and yycFG in the development of decreased susceptibility to vancomycin in Staphylococcus aureus. International Journal of Medical Microbiology, 297, 205–215

Jevons MP. 1961. “Celbenin”-resistant staphylococci. BMJ, 1, 124– 125.

Karamolahi, S., Kaviar, V. H., Haddadi, M. H., Hashemian, M., Feizi, J., Sadeghifard, N., and Khoshnood, S. (2024). Molecular characterization of Staphylococcus aureus isolated from hospital-acquired infections in Ilam, Iran. Molecular biology reports, 51(1), 686.

Klein, E.; Smith, D.L.; Laxminarayan, R. 2007. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999–2005. Emerging Infectious Diseases, 13, 1840.

Klevens, R.M.; Morrison, M.A.; Nadle, J.; Petit, S.; Gershman, K.; Ray, S.; Harrison, L.H.; Lynfield, R.; Dumyati, G.; Townes, J.M.; et al. 2007. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. J. Am. Med. Assoc, 298, 1763–1771.

La Vecchia, A., Ippolito, G., Taccani, V., Gatti, E., Bono, P., Bettocchi, S., et al. 2022. Epidemiology and antimicrobial susceptibility of Staphylococcus aureus in children in a tertiary care pediatric hospital in Milan, Italy, 2017–2021. Italian Journal of Pediatrics, 48, 1–8.

Lebreton, François, and Vincent Cattoir. 2019. "Resistance to glycopeptide antibiotics." Bacterial Resistance to Antibiotics–From Molecules to Man, 51-80.

Lowy, F.D. 1998. Staphylococcus aureus infections. New England Journal of Medicine, 339, 2025–2027.

Mahmood, H. A., and Flayyih, M. T. 2014. Detection of van A gene of Vancomycin resistant Staphylococcus aureus by PCR technique. International Journal of Advanced Research, 2(7), 209-216.

Mahmood, L. J., & Anwer, S. S. 2021. Detection of Vancomycin Resistant Gene in Staphylococcus aureus Isolated From Different Clinical Samples in Erbil City. Journal of University of Babylon for Pure and Applied Sciences, 1-10.

McGuinness WA, Malachowa N, DeLeo FR. 2017. Vancomycin resistance in Staphylococcus aureus. Yale Journal of Biology and Medicine, 90, 269–281

Mlynarczyk-Bonikowska, B., Kowalewski, C., Krolak-Ulinska, A., and Marusza, W. 2022. Molecular mechanisms of drug resistance in Staphylococcus aureus. International journal of molecular sciences, 23(15), 8088.

Moghaddam, P. Z., Azimian, A., Sepahy, A. A., & Iranbakhsh, A. 2021. Isolation and Genetic Characterization of Vancomycin-resistant and mecC+ Methicillin-resistant Staphylococcus aureus Strains in Clinical Samples of Bojnurd, Northeastern Iran. Jundishapur Journal of Microbiology, 14(10).

Mohammed, K. A., Yaqoob, A. K., and Abdulkareem, Z. H. 2021. Characterization of Vancomycin Resistant Staphylococcus Aureus Isolated from Outpatients in Iraq. Annals of the Romanian Society for Cell Biology, 25(6), 18439-18447.

Mohammed, L. S., and Flayyih, M. T. 2017. (Macrolides–Lincosamides-Streptogramins) and Vancomycin Resistance Phenotypes of Staphylococcus aureus Isolated From Clinical Samples by Using Vitek 2 Compact System. Iraqi Journal of Science, 403-407.

Navidinia, M., Zamani, S., Mohammadi, A., Araghi, S., Amini, C., Pourhossein, B., and Goudarzi, M. (2023). Hospital-Related Lineage of USA300 Methicillin-Resistant Staphylococcus aureus (MRSA) to Cause Bacteremia in Iran. BioMed research international, 2023, 8335385.

McNeil, J. C., Sommer, L. M., Joseph, M., Hulten, K. G., and Kaplan, S. L. (2024). Penicillin susceptibility among Staphylococcus aureus skin and soft tissue infections at a children's hospital. Microbiology spectrum, 12(10), e0086924.

Neamah Abbas, Z., Naji Abdullah, H., and Ranjbar, B. (2024). Effect of zinc oxide quantum dots on methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Staphylococcus aureus (VRSA) isolates from Baghdad Hospital by PCR-technique for mecA and vanA genes. Modares Journal of Biotechnology, 15(2), 0-0.

Ogura, K., Kaji, D., Sasaki, M., Otsuka, Y., Takemoto, N., Miyoshi-Akiyama, T., et al. 2022. Predominance of ST8 and CC1/spa-t1784 methicillin-resistant Staphylococcus aureus isolates in Japan and their genomic characteristics. Journal of Global Antimicrobial Resistance. 28, 195–202.

Ozmen Capin, B. B., Tekeli, A., and Karahan, Z. C. 2020. Evaluation of the Presence and Characterization of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Level Resistance Among Bloodstream Isolates of Methicillin-Resistant Staphylococcus aureus. Microbial drug resistance (Larchmont, N.Y.), 26(3), 238–244.

Raheema, R. H., Melek, H. K., & Jassim, A. T. 2021. Characterization of antibiotic resistance of Staphylococcus aureus isolated from patients with diabetic foot ulcers in Wasit Province. International Journal of Science and Research Archive, 3(2), 201-208.

Rasigade JP, Vandenesch F. 2014. Staphylococcus aureus: a pathogen with still unresolved issues. Infection, Genetics and Evolution, 21, 510–4.

Rehm, S.J.; Tice, A. 2010. Staphylococcus aureus: Methicillin-susceptible S. aureus to methicillin-resistant S. aureus and vancomycinresistant S. aureus. Clinical Infectious Diseases, 51 (Suppl. S2), S176–S182.

Reyad Alhamadani, I. M., and Saaid Tuwaij, N. S. 2021. Molecular investigation of vancomycin and beta-lactam resistance genes among vancomycin resistant/intermediate staphylococcus aureus isolates. Biochemical & Cellular Archives, 21(1).

Roch M, Clair P, Renzoni A, Reverdy M-E, Dauwalder O, Bes M, Martra A, Freydière A-M, Laurent F, Reix P, Dumitrescu O, Vandenesch F. 2014. Exposure of Staphylococcus aureus to subinhibitory concentrations of β-lactam antibiotics induces heterogeneous vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother, 58, 5306–5314.

Saito M, Katayama Y, Hishinuma T, Iwamoto A, Aiba Y, KuwaharaArai K, Cui L, Matsuo M, Aritaka N, Hiramatsu K. 2014. “Slow VISA,” a novel phenotype of vancomycin resistance, found in vitro in heterogeneous vancomycin-intermediate Staphylococcus aureus strain Mu3. Antimicrob Agents Chemother, 58, 5024–5035

Sajid, A., Kashif, N., Kifayat, N., & Ahmad, S. 2016. Detection of antibiotic residues in poultry meat. Pakistan journal of pharmaceutical sciences, 29(5), 1691–1694.

Sakamoto, Y., Yamauchi, Y., Jo, T. et al. 2021. In-hospital mortality associated with community-acquired pneumonia due to methicillin-resistant Staphylococcus aureus: a matched-pair cohort study. BMC Pulmonary Medicine, 21, 345.

Salih, H. A., and Salih, M. B. 2019. Molecular detection of enterotoxins (sea) of VRSA and MRSA isolated from restaurant workers in Thi-Qar province at Iraq. Biochemical & Cellular Archives, 19(2).

Sancak, B., Ercis, S., Menemenlioğlu, D., Çolakoğlu, Ş., and Hasçelik, G. 2005. Methicillin-resistant Staphylococcus aureus heterogeneously resistant to vancomycin in a Turkish university hospital. Journal of Antimicrobial Chemotherapy, 56(3), 519-523.

Sancak, B., Yagci, S., Gür, D., Gülay, Z., Ogunc, D., Söyletir, G., ... and Korten, V. 2013. Vancomycin and daptomycin minimum inhibitory concentration distribution and occurrence of heteroresistance among methicillin-resistant Staphylococcus aureus blood isolates in Turkey. BMC infectious diseases, 13, 1-6.

Selim, S., Faried, O. A., Almuhayawi, M. S., Saleh, F. M., Sharaf, M., El Nahhas, N., and Warrad, M. 2022. Incidence of vancomycin-resistant Staphylococcus aureus strains among patients with urinary tract infections. Antibiotics, 11(3), 408.

Shahabinejad, F., Tazerji, S. S., Gharieb, R., and Duarte, P. M. (2024). Phenotypic and genotypic characterization of methicillin and vancomycin-resistant Staphylococcus aureus isolated from human clinical samples in Kerman hospitals, Iran. German Journal of Microbiology, 4(2), 29-38.

Sharma, S., Chauhan, A., Ranjan, A., Mathkor, D. M., Haque, S., Ramniwas, S., ... and Yadav, V. (2024). Emerging challenges in antimicrobial resistance: implications for pathogenic microorganisms, novel antibiotics, and their impact on sustainability. Frontiers in Microbiology, 15, 1403168.

Shekarabi, M., Hajikhani, B., Salimi Chirani, A., Fazeli, M., and Goudarzi, M. 2017. Molecular characterization of vancomycin-resistant Staphylococcus aureus strains isolated from clinical samples: A three year study in Tehran, Iran. PloS one, 12(8), e0183607.

Shoaib, M., Aqib, A. I., Muzammil, I., Majeed, N., Bhutta, Z. A., Kulyar, M. F. E. A., ... and Pu, W. (2023). MRSA compendium of epidemiology, transmission, pathophysiology, treatment, and prevention within one health framework. Frontiers in Microbiology, 13, 1067284.

Tabandeh, M., Kaboosi, H., Taghizadeh Armaki, M., Pournajaf, A., and Peyravii Ghadikolaii, F. 2022. New update on molecular diversity of clinical Staphylococcus aureus isolates in Iran: Antimicrobial resistance, adhesion and virulence factors, biofilm formation and SCCmec typing. Molecular Biology Reports, 49, 3099–3111.

Taha, A. B., & Al-Salihi, S. M. S. 2014. Staphylococcus aureus with reduced vancomycin susceptibility among clinical isolates in Erbil City. Zanco Journal of Medical Sciences (Zanco J Med Sci), 18(1), 651_658-651_658.

Tang, J.; Hu, J.; Kang, L.; Deng, Z.; Wu, J.; Pan, J. 2015. The use of vancomycin in the treatment of adult patients with methicillin-resistant Staphylococcus aureus (MRSA) infection: A survey in a tertiary hospital in China. International Journal of Clinical and Experimental Medicine , 8, 19436.

Tsuzuki, S.; Matsunaga, N.; Yahara, K.; Gu, Y.; Hayakawa, K.; Hirabayashi, A.; Kajihara, T.; Sugai, M.; Shibayama, K.; Ohmagari, N. 2020. National trend of blood-stream infection attributable deaths caused by Staphylococcus aureus and Escherichia coli in Japan. Journal of Infection and Chemotherapy, 26, 367–371.

United Nations. Last accessed date on 5 June 2023. Available from World Population Prospects - Population Division - United Nations

Vellappally, S., Divakar, D. D., Al Kheraif, A. A., Ramakrishnaiah, R., Alqahtani, A., Dalati, M. H. N., ... and Harikrishna Varma, P. R. 2017. Occurrence of vancomycin-resistant Staphylococcus aureus in the oral cavity of patients with dental caries. Acta microbiologica et immunologica Hungarica, 64(3), 343-351.

Vestergaard, M., Frees, D., and Ingmer, H. 2019. Antibiotic resistance and the MRSA problem. Microbiology spectrum, 7(2), 10-1128.

Weigel LM, Clewell DB, Gill SR, Clark NC, McDougal LK, Flannagan SE, Kolonay JF, Shetty J, Killgore GE, Tenover FC. 2003. Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science, 302:1569–1571.

Wootton M, MacGowan AP, Walsh TR, Howe RA. 2007. A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides. Journal of Clinical Microbiology, 45(2):329–332.

Xu, B., Gutierrez, B., Mekaru, S., Sewalk, K., Goodwin, L., Loskill, A., ... and Kraemer, M. U. 2020. Epidemiological data from the COVID-19 outbreak, real-time case information. Scientific data, 7(1), 106.

Yassen, M. A. R. 2016. Association of methicillin and vancomycin antibiotics resistance in Staphylococcus aureus isolated from wound infection patients. Muthanna Medical Journal, 3(2).

Zakaria, N. D., Hamzah, H. H., Salih, I. L., Balakrishnan, V., and Abdul Razak, K. 2023. A Review of Detection Methods for Vancomycin-Resistant Enterococci (VRE) Genes: From Conventional Approaches to Potentially Electrochemical DNA Biosensors. Biosensors, 13(2), 294.

Zefenkey, Z. 2022. The Impact of the Three Most Common Hand Cleansing Methods on the Bacterial Profile: A Randomized Clinical Trial. Iberoamerican Journal of Medicine, 4(1), 4-10.